1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
- Contribution to journal › Article
-
Mark
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity
- Contribution to journal › Article
-
Mark
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
- Contribution to journal › Article
-
Mark
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
- Contribution to journal › Article
- 2024
-
Mark
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
- Contribution to journal › Article
-
Mark
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
- Contribution to journal › Article
-
Mark
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
- Contribution to journal › Article
-
Mark
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer
- Contribution to journal › Article
- 2023
-
Mark
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
- Contribution to journal › Article